Factors associated with delayed cancer diagnosis in egyptian children

Er Abdelkhalek1, Lm Sherief1, Nm Kamal2

  • 1Pediatric Department, Faculty of Medicine, Zagazig University, Egypt. ; Pediatric Department, Banha Children's Hospital, Egypt.

Insights

Delayed diagnosis of childhood cancer in Egypt is linked to younger age, lower socioeconomic status, and parental education. Cancer type and location also significantly impact diagnosis timelines, highlighting areas for intervention.

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Public Health

Background:

  • Early diagnosis of childhood cancer is crucial for improved outcomes and quality of life.
  • Limited research exists on diagnostic delays for pediatric cancers in Egypt.
  • This study addresses the need to understand factors contributing to delayed cancer diagnosis in Egyptian children.

Purpose of the Study:

  • To investigate delays in the diagnosis of childhood cancers in Egypt.
  • To identify patient, socioeconomic, and clinical factors associated with these diagnostic delays.

Main Methods:

  • Retrospective analysis of 172 children with cancer from two pediatric oncology units.
  • Examination of the interval between symptom onset and final diagnosis.
  • Univariate and multivariate analyses to correlate delays with patient demographics, socioeconomic status, parental education, malignancy type, and tumor site.

Main Results:

  • Median total diagnostic delay was 47 days, with patient/parent factors contributing 8 days and diagnostic delays 28 days.
  • Significant factors for delay included younger age (<5 years), lower parental education, and socioeconomic status.
  • Malignancy type and site were significant; germ cell tumors and leukemia had shorter delays, while brain tumors had longer delays. Missed diagnoses occurred in 39.5% of cases.

Conclusions:

  • Delayed diagnosis in childhood cancer is associated with patient age, family socioeconomic status, parental education, and cancer type/site.
  • Interventions should focus on raising awareness and addressing identified contributing factors.
  • Developing targeted strategies is essential to improve early detection and intervention for pediatric cancers in Egypt.
Abstract

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.5K
Cancer Prevention02:59

Cancer Prevention

2.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
857
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
941